Pharmaceutical Policy

Publications authored by CHSPR faculty and staff from 2009 to the present are listed here. Older peer-reviewed publications are usually available from individual journals and can be searched for using PubMed. Older reports published by CHSPR (from 1973) are available from the UBC Library cIRcle database. If you cannot find a specific publication, please contact us.


Morgan S, Daw J, Thomson P. International best practices for negotiating 'reimbursement contracts' with price rebates from pharmaceutical companies. Health Aff (Millwood). 2013 Apr;32(4):771-7. Read more

Law MR. Money left on the table: generic drug prices in Canada. Healthc Policy. 2013 Feb;8(3):17-25. Read more

Morgan SG, Thomson PA, Daw JR, Friesen MK. Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces. BMC Health Serv Res. 2013 Jan 31;13:34. Read more

Allin S, Bayoumi AM, Law MR, Laporte A. Comparability of self-reported medication use and pharmacy claims data. Health Rep. 2013 Jan 16;24(1):3-9. Read more

Law MR, Heard D, Fisher J, Douillard J, Muzika G, Sketris IS. The geographic accessibility of pharmacies in Nova Scotia. Can Pharm J (Ott). 2013 Jan;146(1):39-46. Read more

So L, Morgan SG, Quan H. Does concordance between survey responses and administrative records differ by ethnicity for prescription medication? J Popul Ther Clin Pharmacol. 2012;19(2):e248-58. Read more

Law M. Canadians pay too much for generic drugs. In: Roos N, Manson Singer S, O’Grady K, Tapp C, Turczak S. Canadian health policy in the news: why evidence matters. University of Manitoba: Evidence Network, 2012; 334-37. Read more

Morgan SG, Thomson PA, Daw JR, Friesen MK, Dijkstra A. The public provision of pharmaceuticals: a synthesis of policies in ten developed countries. Vancouver (BC): Pharmaceutical Policy Research Collaboration; Dec 2012. Read more

Morgan SG, Cunningham C, Law MR. Drug development: innovation or imitation deficit? BMJ. 2012 Sep 4;345:e5880. Read more

Puyat JH, Law MR, Wong ST, Sutherland JM, Morgan SG. The essential and potentially inappropriate use of antipsychotics across income groups: an analysis of linked administrative data. Can J Psychiatry. 2012 Aug;57(8):488-95. Read more

Morgan SG, Daw JR. Canadian pharmacare: looking back, looking forward. Healthc Policy. 2012 Aug;8(1):14-23. Read more

Kaplan CP, Kim SE, Wong ST, Sawaya GF, Walsh JM, Pérez-Stable EJ. Willingness to use tamoxifen to prevent breast cancer among diverse women.Breast Cancer Res Treat. 2012 May;133(1):357-66. Read more

Greyson DL, Cunningham C, Morgan S. Information behaviour of Canadian pharmaceutical policy makers. Health Info Libr J. 2012 Mar;29(1):16-27. Read more

Law MR, Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012 Feb 21;184(3):297-302. Read more

Law MR, Ma T, Fisher J, Sketris IS. Independent pharmacist prescribing in Canada. Can Pharm J (Ott). 2012 Jan;145(1):17-23.e1. Read more

Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clin Ther. 2012 Jan;34(1):239-249.e2. Read more

Daw JR, Morgan SG. Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.  Health Policy. 2012 Jan;104(1):19-26. Read more

Morgan S, Cunningham C, Law M. Changes, challenges, and innovations in pharmaceutical expenditure management. Washington (DC): Commonwealth Fund, 2011 International Symposium on Health Care Policy; 2011. Read more

Law MR, Kawasumi Y, Morgan SG. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov. Health Aff (Millwood). 2011 Dec;30(12):2338-45. Read more

Morgan S, Hanley G, Cunningham C, Quan H. Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data. Open Med. 2011;5(2):e87-93. Read more